InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: Rob_ post# 95699

Tuesday, 03/24/2015 5:47:07 PM

Tuesday, March 24, 2015 5:47:07 PM

Post# of 403241
This is a well-reasoned response. K as the drug for those who want to do something with little in the way of side effects. Let's see how it shakes out: can K offer much help in such a scenario?

With the understanding that for the vast majority of pts you will want to hit your tumor hard, not gently.

You could be onto something though, if it works. But consider: My own family situation, metastatic pancreatic CA, many cycles of FOLFIRINOX, significant toxicity from platinum agents(peripheral neuropathy), and the lovely individual with the disease says treat me aggressively, I would rather be alive in a wheelchair rather than dead. But there are many types of cancer and many types of patients, and I hope K could have such a role.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News